Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-08-31
1997-05-20
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31335
Patent
active
056312784
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
Protozoans infect and kill millions of people annually. However, in most cases, efficacious chemotherapeutic agents and vaccines are unavailable to treat these diseases.
Human malaria, caused by a protozoan sporozoa, is an acute and chronic protozoal disease caused by four species of plasmodia, namely Plasmodium falciparum, P. vivax, P. ovale and P. malariae. P. falciparum is the most virulent of these and the only one that kills acutely. The plasmodial parasites are transmitted by female mosquitoes of several species of the genus Anopheles. The World Health Organization recognizes malaria as the world's major primary health problem, causing more morbidity and mortality than any other disease. An estimated 300-500 million cases occur annually resulting in 3-5 million deaths, mostly among children. Malaria is a serious problem mainly in the tropical and subtropical world, especially Africa, South and Central America, India and Southeast Asia. Isolated cases of malaria have recently been reported in the southeastern and southwestern United States. The drug chloroquine is often used to treat malaria, however, the rapid spread of chloroquine-resistant P. falciparum and the lack of a malaria vaccine emphasizes the long-felt need to develop new strategies and agents for controlling this disease.
Babesiosis, an infection by protozoan sporozoa of the genus Babesia, is transmitted by hard-bodied ticks. The causative organisms, parasites resembling those of malaria, invade and destroy erythrocytes. Babesia infections in wild and domestic animals occur worldwide and are well known in veterinary medicine. Human infections are more rare and occur exclusively in Europe and North America. In many countries, Babesia is responsible for serious economic losses to the exclusively in Europe and North America. In many countries, Babesia is responsible for serious economic losses to the: livestock industry. No effective chemotherapeutic treatment or vaccine has been known for treatment of babesiosis.
Chagas disease (American trypanosomiasis) is a zoonotic infection caused by the protozoan Trypanosoma cruzi. It affects as many as 15 million people living in South and Central America. African Trypanosomiasis (Sleeping sickness) is a chronic infection with Trypanosoma brucei gambiense or an acute one with T.B. rhodesiense. These hemoflagellate protozoa are transmitted cyclically by several species of blood-sucking tsetse flies of the genus Glossind. There are no efficacious and safe drugs for treating the chronic forms of these infections.
Taxol is a diterpenoid isolated from the stem bark of the western yew, Taxus brevifolia. Taxol is a mitotic spindle poison that stabilizes microtubules and inhibits their depolymerization to free tubulin. Taxol has been demonstrated to possess antineoplastic activity and has been identified as an anti-cancer agent, particularly in the treatment of advanced ovarian cancer.
Over ten years ago, Baum et al. Proceeding of the National Academy of Science, U.S.A. 1981, 78, 4571-4575, found that taxol inhibited the flagellate protozoan Trypanosoma cruzi. Trypanosomes, being flagellated protozoans, belong to the protozoal Phylum mastigophora. Baum et al. found that the addition of taxol inhibited the replication of T. cruzi in a dose-dependent fashion. Baum et al. treated cultures containing trypanosomes with 1 .mu.M to 10 .mu.M of taxol. However, treatment of trypanosomiasis was never developed and there are presently no efficacious and safe drugs for treating these infections, particularly the chronic forms. Mastigophora, such as the Trypanosoma and Leishmania species, are flagellated protozoans that asexually reproduce by binary fission. This is quite different than the Protozoa Sporozoa, which includes the Plasmodium, Toxoplasma, Isospora, Sarcocystis, Crytosporidium and Pneumocystis species, which reproduce by asexual (schizogony) and sexual (sporogony) multiplication. Another important distinguishing feature of the Mastigophora from the Sporozoa is the unique microtubul
REFERENCES:
patent: 4814470 (1989-03-01), Colin et al.
patent: 4857653 (1989-08-01), Colin et al.
patent: 4876399 (1989-10-01), Holton et al.
patent: 4924011 (1990-05-01), Denis et al.
patent: 4942184 (1990-07-01), Haugwitz et al.
patent: 4960790 (1990-10-01), Stella et al.
patent: 5015744 (1991-05-01), Holton
patent: 5019504 (1991-05-01), Christen et al.
patent: 5059699 (1991-10-01), Kingston et al.
patent: 5356927 (1994-10-01), Taraschi et al.
Baum, S. et al., "Taxol, a Microtubule Stabilizing Agent, Blocks the Replication of Trypanosoma cruzi", PNAS USA 1981, 78(7), 4571-4575.
Denis, J.-N. et al., "Direct, Highly Efficient Synthesis from (S)-(+)-Phenylglycine of the Taxol and Taxotere Side Chains", J. Org. Chem. 1991, 56, 6939-6942.
Dieckmann-Schuppert, A. et al., "Mode of Action of Tubulozoles Against Plasmodium falciparum In Vitro", Antimicrobial Agents adn Chemotherapy 1990, 34(8), 1529-1534.
Fuerst, R., Chapter 41 in "Frobisher and Fuerst's Microbiology in Health and Disease", Chap. 41, W. B. Saunders Company, 1983, USA, pp. 600-605.
Kaminsky, R. et al., "Feeder Layer-free In Vitro Assay for Screening Antitrypanosomal Compounds Against Trypanosoma brucei brucei and T. b. evansi", Chemical Abstracts 1989, 111, Abstract, No. 53655j.
Kumar, N. et al., "Plasmodium gallinaceum: Critical Role for Microtubules in the Transformation of Zygotes into Ookinetes", Exp. Parasitol. 59(2), 239-247 in Embase Abstract No. 85110113 1985.
Singleton, P. et al., "Dictionary of Microbiology and Molecular Biology", (2nd Ed.) John Wiley & Sons, New York, 1987, pp. 239, 468, 494, 688, 790 and 898.
Pouvelle Bruno
Taraschi Theodore F.
Henley III Raymond
Thomas Jefferson University
LandOfFree
Methods of killing protozoal parasites does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of killing protozoal parasites, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of killing protozoal parasites will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724238